| Nov 15 |
Allurion Technologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Nov 13 |
Allurion Technologies reports Q3 results
|
| Nov 13 |
Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript
|
| Nov 13 |
Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Nov 13 |
Earnings Scheduled For November 13, 2024
|
| Nov 4 |
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference
|
| Oct 30 |
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
|
| Oct 23 |
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon
|
| Oct 9 |
Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss
|
| Oct 2 |
Allurion started at buy by Jefferies ahead of data for obesity therapy
|
